Evidence map›Paper›PMID 35453887›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Diagnostic Value of IP-10 Level in Plasma and Bronchoalveolar Lavage Fluid in Children with Tuberculosis and Other Lung Diseases.

Agnieszka Strzelak, Anna Komorowska-Piotrowska, Katarzyna Krenke, Wioletta Zagórska, Witold Bartosiewicz, Wojciech Feleszko, Marek Kulus

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Agnieszka StrzelakDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Anna Komorowska-PiotrowskaDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-5034-538X
Katarzyna KrenkeDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Wioletta ZagórskaDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Witold BartosiewiczDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Wojciech FeleszkoDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-6613-2012
Marek KulusDepartment of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-5360-4372
Medical University of Warsaw · PL

Funding

Medical University of Warsaw WUM/1W34/2015/2016
6 · The paper itself

Abstract

objectivesIP-10 has been proposed as a new diagnostic biomarker for

aimTo determine IP-10 levels in unstimulated BALF and plasma in children with and without MTBI.

methodsIP-10 concentrations in BALF and plasma were measured in children hospitalized with suspected tuberculosis or other respiratory disease and scheduled for bronchoscopy. Thirty-five children were enrolled: 13 with suspected tuberculosis and 22 controls. The association between IP-10 and age was examined.

resultsThe IP-10 expression was increased in BALF compared to plasma (

conclusionsIP-10 is detectable in unstimulated BALF in children with respiratory diseases, reaches higher concentrations in unstimulated BALF vs plasma, and does not correlate with age. However, it could not discriminate MTBI from other respiratory diseases.

Indexed as

biomarkerbronchoscopychildCXCL10latent tuberculosis infection

Identifiers

PMID35453887
PMCPMC9032840
OpenAlexW4220845918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.